NFE2L2 and lung cancer: Notably, in HT-1080 fibrosarcoma cells and H1299 lung cancer cells, NFE2L2 overexpression or KEAP1 gene disruption can promote ferroptosis resistance even in cells lacking GPX4 (17, 50).